Month: April 2023

UTRECHT, The Netherlands and CAMBRIDGE, Mass., April 14, 2023 (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today announced the publication of an abstract for a poster presentation of early clinical data on the bispecific antibody petosemtamab in advanced gastric/esophageal adenocarcinoma (GEA) at the American Association for Cancer Research (AACR) Annual Meeting 2023 taking place in Orlando, Florida April 14-19, 2023. Petosemtamab, or MCLA-158, is a human IgG1 Biclonics® designed to bind to cancer cells expressing epidermal growth factor receptor (EGFR) and leucine-rich repeat-containing G protein-coupled receptor 5 (LGR5). Petosemtamab is in clinical development in the expansion...

– Robust 36% overall response rate (ORR) in 42 evaluable patients – 6 months median duration of response with 17 patients still on treatment as of Nov. 28, 2022 data cutoff – End-of-Phase meeting with U.S. Food & Drug Administration provides clarity to potential registration path in HNSCC – Investor call on April 17, 2023 at 6:30 p.m. ET ET UTRECHT, The Netherlands and CAMBRIDGE, Mass., April 14, 2023 (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq: MRUS) (Merus, the Company, we, or our), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today announced the publication of an abstract for a plenary session oral presentation of interim clinical data on the bispecific antibody petosemtamab in previously treated head and neck squamous cell...

ISS, an independent, third-party proxy advisory firm, recommends Sernova’s shareholders vote FOR all management’s director nominees using ONLY management’s WHITE proxy. ISS notes the dissidents failed to present a detailed explanation of their case and there does not seem to be a compelling case that change at Sernova is warranted at this time. Shareholders who have questions or need assistance with voting their shares should contact Sernova Corp.’s strategic advisor and proxy solicitation agent Laurel Hill Advisory Group by telephone at 1-877-452-7184 or by email at assistance@laurelhill.com.LONDON, Ontario, April 14, 2023 (GLOBE NEWSWIRE) — Sernova Corp. (“Sernova” or the “Corporation”) (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a clinical-stage company and leader in cell therapeutics, is pleased to announce that Institutional...

Hässleholm 2023-04-14The Nomination Committee has been informed that Carina Håkansson declines new election to the Board of Directors at the upcoming Annual General Meeting in Eolus, and the Nomination Committee therefore revises its proposal for Board composition ahead of the Annual General Meeting 2023. With an amendment to what is stated in the notice to the Annual General Meeting, the Nomination Committee thus proposes that the number of Board members should comprise of a total of six Board members to be elected by the meeting, with no deputies, and that the Board members Hans Johansson, Jan Johansson, Hans Linnarson, Bodil Rosvall Jönsson and Hans-Göran Stennert should be re-elected as Board members and that Marie Grönborg should be elected as new board member. Eolus will publish an updated form for notification of participation...

ZIBO, China, April 14, 2023 (GLOBE NEWSWIRE) — Sunrise New Energy Co., Ltd. (“Sunrise”, the “Company”, “we” or “our”) (NASDAQ: EPOW), today announced that the revenues for the first 3 months of 2023, ending March 31st, reached $8 million compared to $440,000 in the first 3 months of 2022, an increase of 1,718%. During the first 3 months of 2023 the company produced and shipped over 1,350 metric tons of graphite anode. The Company also announced that its Chairman, Mr. Haiping Hu has recently acquired 20,000 shares of EPOW stock at an average of $2.78. “The team at Sunrise has executed quickly emerged as a leading manufacturer of graphite anode,” said Sunrise New Energy’s Chairman Mr. Haiping Hu. “Yet despite all the positive accomplishments, including the results announced today and the closing of purchase orders worth $700 million,...